Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting.

"Declarations Ethics approval and consent to participateThe Queen’s University Health Sciences Research Ethics Board approved this study. Verbal consent was obtained from participants prior to their enrollment and participation in this study. Competing interestsDAT and AKE have the following disclosures that pose no conflict of interest to the current manuscript. DAT speaker for ALK, ABBVIE, ROHE. AKE has participated in the advisory boards for ALK Abello, AstraZeneca, Aralez, Bausch Health, Circassia Ltd, GlaxoSmithKline, Johnson & Johnson, Merck, Mylan, Novartis, Pediapharm, and Pfizer; has been a speaker for ALK, Aralez, AstraZeneca, Boehringer-Ingelheim, CACME, Meda, Mylan, Merck, Novartis, Pediapharm, Pfizer, The ACADEMY, and Takeda; has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Regeneron, and Sanofi, through her institution; and has served as an independent consultant to Allergy Therapeutics, Bayer LLC, Ora Inc and Regeneron in the past. All remaining authours declare that they have no competing conflicts of interest. Competing interests DAT and AKE have the following disclosures that pose no conflict of interest to the current manuscript. DAT speaker for ALK, ABBVIE, ROHE. AKE has participated in the advisory boards for ALK Abello, AstraZeneca, Aralez, Bausch Health, Circassia Ltd, GlaxoSmithKline, Johnson & Johnson, Merck, Mylan, Novartis, Pediapharm, and Pfizer; has been a speaker for ALK, Aralez, AstraZeneca, Boehringer-Ingelheim, CACME, Meda, Mylan, Merck, Novartis, Pediapharm, Pfizer, The ACADEMY, and Takeda; has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Regeneron, and Sanofi, through her institution; and has served as an independent consultant to Allergy Therapeutics, Bayer LLC, Ora Inc and Regeneron in the past. All remaining authours declare that they have no competing conflicts of interest."

"Funding This project was supported by funding from the Public Health Agency of Canada, through the COVID-19 Immunity Task Force. Additional funding was recieved from Queen’s University Vice President Research, Queen’s University Department of Medicine Research Award- CIHR Pillar, Queen’s Faculty of Health Sciences, School of Medicine and School of Nursing. "